Sintx Technologies, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -100.0% over 5Y.
today you would have $0.07▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $3.86 | $3.50 | $76.20 | $1,936.00 | |
| P/S | 6.3x | 20.8x | 3.8x | 1.7x | 8.7x |
| P/B | 1.1x | 5.2x | 1.2x | 0.2x | 0.9x |
| EPS | -$6.16 | -$15.19 | -$624.47 | -$12,162.00 | |
| Profit margin | -1153.21% | -1421.67% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BFRGBullFrog AI Holdings, Inc. | $0.54 | — | 1.4x | — | -130.71% | $10.01M |
| INABIn8bio Inc | $1.04 | — | 0.6x | — | -111.11% | $10.2M |
| AMSAmerican Shared Hospital Services | $1.47 | — | 0.4x | — | -12.06% | $9.78M |
| FBLGFibroBiologics, Inc. | $1.44 |
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Company description provided by Yahoo Finance.
| -884.75% |
| -673.65% |
| -2003.16% |
| ROE | -247.08% | -353.84% | -283.10% | -94.15% | -211.06% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 1.9x |
| — |
| -660.08% |
| $9.59M |
| APUSApimeds Pharmaceuticals US, Inc. | $6.30 | — | 9.7x | — | — | $9.51M |
| APREAprea Therapeutics, Inc. | $0.84 | — | 0.3x | — | -46.15% | $10.56M |